A	O
New	O
Intraoperative	O
Protocol	O
for	O
Reducing	B:C0376101
Perioperative	I:C0376101
Transfusions	I:C0376101
in	O
Cardiac	O
Surgery	I:C0018821
.	O

A	O
New	O
Intraoperative	O
Protocol	O
for	O
Reducing	O
Perioperative	I:C0376101
Transfusions	I:C0376101
in	O
Cardiac	B:C0018821
Surgery	I:C0018821
.	O

Perioperative	O
anemia	B:C0002871
and	O
blood	O
product	I:C0005841
transfusion	I:C0005841
increases	O
short	O
-	O
term	O
and	O
long	O
-	O
term	O
morbidity	O
and	O
mortality	O
during	O
cardiac	O
surgery	I:C0018821
.	O

Perioperative	O
anemia	O
and	O
blood	B:C0005841
product	I:C0005841
transfusion	I:C0005841
increases	O
short	O
-	O
term	O
and	O
long	O
-	O
term	O
morbidity	O
and	O
mortality	O
during	O
cardiac	O
surgery	I:C0018821
.	O

Perioperative	O
anemia	O
and	O
blood	O
product	I:C0005841
transfusion	I:C0005841
increases	O
short	O
-	O
term	O
and	O
long	O
-	O
term	O
morbidity	O
and	O
mortality	O
during	O
cardiac	B:C0018821
surgery	I:C0018821
.	O

We	O
hypothesized	O
that	O
streamlined	O
cardiopulmonary	O
bypass	O
circuit	O
and	O
rotational	B:C3661505
thromboelastometry	I:C3661505
(	O
rotational	O
thromboelastometry	I:C3661505
)	O
would	O
reduce	O
blood	O
product	I:C0005841
usage	I:C0005841
and	O
improve	O
outcomes	O
.	O

We	O
hypothesized	O
that	O
streamlined	O
cardiopulmonary	O
bypass	O
circuit	O
and	O
rotational	O
thromboelastometry	I:C3661505
(	O
rotational	B:C3661505
thromboelastometry	I:C3661505
)	O
would	O
reduce	O
blood	O
product	I:C0005841
usage	I:C0005841
and	O
improve	O
outcomes	O
.	O

We	O
hypothesized	O
that	O
streamlined	O
cardiopulmonary	O
bypass	O
circuit	O
and	O
rotational	O
thromboelastometry	I:C3661505
(	O
rotational	O
thromboelastometry	I:C3661505
)	O
would	O
reduce	O
blood	B:C0005841
product	I:C0005841
usage	I:C0005841
and	O
improve	O
outcomes	O
.	O

All	O
patients	O
with	O
Society	B:C3164380
of	I:C3164380
Thoracic	I:C3164380
Surgeons	I:C3164380
risk	I:C3164380
scores	I:C3164380
at	O
our	O
institution	O
from	O
January	O
2013	O
to	O
June	O
2015	O
were	O
included	O
.	O

All	O
patients	O
with	O
Society	O
of	I:C3164380
Thoracic	I:C3164380
Surgeons	I:C3164380
risk	I:C3164380
scores	I:C3164380
at	O
our	O
institution	B:C2607850
from	O
January	O
2013	O
to	O
June	O
2015	O
were	O
included	O
.	O

Individuals	O
were	O
chronologically	O
stratified	O
into	O
2	O
groups	O
according	O
to	O
institutional	B:C0021626
changes	I:C0021626
to	O
a	O
streamlined	O
bypass	O
circuit	O
and	O
rotational	O
thromboelastometry	I:C3661505
-	O
guided	O
transfusion	O
.	O

Individuals	O
were	O
chronologically	O
stratified	O
into	O
2	O
groups	O
according	O
to	O
institutional	O
changes	I:C0021626
to	O
a	O
streamlined	O
bypass	O
circuit	O
and	O
rotational	B:C3661505
thromboelastometry	I:C3661505
-	O
guided	O
transfusion	O
.	O

Individuals	O
were	O
chronologically	O
stratified	O
into	O
2	O
groups	O
according	O
to	O
institutional	O
changes	I:C0021626
to	O
a	O
streamlined	O
bypass	O
circuit	O
and	O
rotational	O
thromboelastometry	I:C3661505
-	O
guided	O
transfusion	B:C0005841
.	O

Blood	B:C0005841
product	I:C0005841
transfusion	I:C0005841
,	O
hematocrit	O
,	O
and	O
observed	O
to	O
expected	O
outcomes	I:C2963499
(	O
O/E	O
)	O
were	O
compared	O
between	O
the	O
groups	O
.	O

Blood	O
product	I:C0005841
transfusion	I:C0005841
,	O
hematocrit	B:C1542366
,	O
and	O
observed	O
to	O
expected	O
outcomes	I:C2963499
(	O
O/E	O
)	O
were	O
compared	O
between	O
the	O
groups	O
.	O

Blood	O
product	I:C0005841
transfusion	I:C0005841
,	O
hematocrit	O
,	O
and	O
observed	O
to	O
expected	B:C2963499
outcomes	I:C2963499
(	O
O/E	O
)	O
were	O
compared	O
between	O
the	O
groups	O
.	O

Patients	O
were	O
defined	O
as	O
either	O
control	O
group	O
(	O
533	O
patients	O
,	O
12	O
months	O
)	O
or	O
intervention	B:C2986530
group	I:C2986530
(	O
804	O
patients	O
,	O
18	O
months	O
)	O
.	O

The	O
intervention	B:C2986530
group	I:C2986530
was	O
further	O
subdivided	O
into	O
streamlined	O
circuit	O
(	O
290	O
patients	O
,	O
6	O
months	O
)	O
and	O
rotational	O
thromboelastometry	I:C3661505
(	O
514	O
patients	O
,	O
12	O
months	O
)	O
.	O

The	O
intervention	O
group	I:C2986530
was	O
further	O
subdivided	O
into	O
streamlined	O
circuit	O
(	O
290	O
patients	O
,	O
6	O
months	O
)	O
and	O
rotational	B:C3661505
thromboelastometry	I:C3661505
(	O
514	O
patients	O
,	O
12	O
months	O
)	O
.	O

Use	O
of	O
streamlined	O
bypass	O
circuit	O
correlated	O
with	O
significantly	O
reduced	O
intraoperative	O
transfusion	B:C0005841
of	O
packed	O
red	I:C2316467
blood	I:C2316467
cells	I:C2316467
(	O
packed	O
red	I:C2316467
blood	I:C2316467
cells	I:C2316467
)	O
(	O
23.8	O
%	O
versus	O
17.9	O
%	O
;	O
p	O
=	O
0.05	O
)	O
and	O
platelets	O
(	O
28.0	O
%	O
versus	O
19.3	O
;	O
p	O
=	O
0.01	O
)	O
with	O
improvement	O
in	O
lowest	O
intraoperative	O
hematocrit	O
(	O
26.0	O
versus	O
26.9	O
;	O
p	O
=	O
0.02	O
)	O
.	O

Use	O
of	O
streamlined	O
bypass	O
circuit	O
correlated	O
with	O
significantly	O
reduced	O
intraoperative	O
transfusion	O
of	O
packed	B:C2316467
red	I:C2316467
blood	I:C2316467
cells	I:C2316467
(	O
packed	O
red	I:C2316467
blood	I:C2316467
cells	I:C2316467
)	O
(	O
23.8	O
%	O
versus	O
17.9	O
%	O
;	O
p	O
=	O
0.05	O
)	O
and	O
platelets	O
(	O
28.0	O
%	O
versus	O
19.3	O
;	O
p	O
=	O
0.01	O
)	O
with	O
improvement	O
in	O
lowest	O
intraoperative	O
hematocrit	O
(	O
26.0	O
versus	O
26.9	O
;	O
p	O
=	O
0.02	O
)	O
.	O

Use	O
of	O
streamlined	O
bypass	O
circuit	O
correlated	O
with	O
significantly	O
reduced	O
intraoperative	O
transfusion	O
of	O
packed	O
red	I:C2316467
blood	I:C2316467
cells	I:C2316467
(	O
packed	B:C2316467
red	I:C2316467
blood	I:C2316467
cells	I:C2316467
)	O
(	O
23.8	O
%	O
versus	O
17.9	O
%	O
;	O
p	O
=	O
0.05	O
)	O
and	O
platelets	O
(	O
28.0	O
%	O
versus	O
19.3	O
;	O
p	O
=	O
0.01	O
)	O
with	O
improvement	O
in	O
lowest	O
intraoperative	O
hematocrit	O
(	O
26.0	O
versus	O
26.9	O
;	O
p	O
=	O
0.02	O
)	O
.	O

Use	O
of	O
streamlined	O
bypass	O
circuit	O
correlated	O
with	O
significantly	O
reduced	O
intraoperative	O
transfusion	O
of	O
packed	O
red	I:C2316467
blood	I:C2316467
cells	I:C2316467
(	O
packed	O
red	I:C2316467
blood	I:C2316467
cells	I:C2316467
)	O
(	O
23.8	O
%	O
versus	O
17.9	O
%	O
;	O
p	O
=	O
0.05	O
)	O
and	O
platelets	B:C0005821
(	O
28.0	O
%	O
versus	O
19.3	O
;	O
p	O
=	O
0.01	O
)	O
with	O
improvement	O
in	O
lowest	O
intraoperative	O
hematocrit	O
(	O
26.0	O
versus	O
26.9	O
;	O
p	O
=	O
0.02	O
)	O
.	O

Use	O
of	O
streamlined	O
bypass	O
circuit	O
correlated	O
with	O
significantly	O
reduced	O
intraoperative	O
transfusion	O
of	O
packed	O
red	I:C2316467
blood	I:C2316467
cells	I:C2316467
(	O
packed	O
red	I:C2316467
blood	I:C2316467
cells	I:C2316467
)	O
(	O
23.8	O
%	O
versus	O
17.9	O
%	O
;	O
p	O
=	O
0.05	O
)	O
and	O
platelets	O
(	O
28.0	O
%	O
versus	O
19.3	O
;	O
p	O
=	O
0.01	O
)	O
with	O
improvement	O
in	O
lowest	O
intraoperative	O
hematocrit	B:C0518014
(	O
26.0	O
versus	O
26.9	O
;	O
p	O
=	O
0.02	O
)	O
.	O

rotational	B:C3661505
thromboelastometry	I:C3661505
was	O
associated	O
with	O
a	O
further	O
reduction	O
in	O
intraoperative	O
packed	O
red	I:C2316467
blood	I:C2316467
cells	I:C2316467
(	O
17.9	O
%	O
versus	O
11.28	O
%	O
;	O
p	O
=	O
0.01	O
)	O
and	O
postoperative	O
transfusion	O
packed	O
red	I:C2316467
blood	I:C2316467
cells	I:C2316467
(	O
38.3	O
%	O
versus	O
23.5	O
%	O
;	O
p	O
=	O
0.02	O
)	O
.	O

rotational	O
thromboelastometry	I:C3661505
was	O
associated	O
with	O
a	O
further	O
reduction	O
in	O
intraoperative	O
packed	B:C2316467
red	I:C2316467
blood	I:C2316467
cells	I:C2316467
(	O
17.9	O
%	O
versus	O
11.28	O
%	O
;	O
p	O
=	O
0.01	O
)	O
and	O
postoperative	O
transfusion	O
packed	O
red	I:C2316467
blood	I:C2316467
cells	I:C2316467
(	O
38.3	O
%	O
versus	O
23.5	O
%	O
;	O
p	O
=	O
0.02	O
)	O
.	O

rotational	O
thromboelastometry	I:C3661505
was	O
associated	O
with	O
a	O
further	O
reduction	O
in	O
intraoperative	O
packed	O
red	I:C2316467
blood	I:C2316467
cells	I:C2316467
(	O
17.9	O
%	O
versus	O
11.28	O
%	O
;	O
p	O
=	O
0.01	O
)	O
and	O
postoperative	O
transfusion	B:C0005841
packed	O
red	I:C2316467
blood	I:C2316467
cells	I:C2316467
(	O
38.3	O
%	O
versus	O
23.5	O
%	O
;	O
p	O
=	O
0.02	O
)	O
.	O

rotational	O
thromboelastometry	I:C3661505
was	O
associated	O
with	O
a	O
further	O
reduction	O
in	O
intraoperative	O
packed	O
red	I:C2316467
blood	I:C2316467
cells	I:C2316467
(	O
17.9	O
%	O
versus	O
11.28	O
%	O
;	O
p	O
=	O
0.01	O
)	O
and	O
postoperative	O
transfusion	O
packed	B:C2316467
red	I:C2316467
blood	I:C2316467
cells	I:C2316467
(	O
38.3	O
%	O
versus	O
23.5	O
%	O
;	O
p	O
=	O
0.02	O
)	O
.	O

The	O
combination	O
was	O
associated	O
with	O
reduced	O
intraoperative	O
(	O
44.6	O
%	O
versus	O
34.1	O
;	O
p	O
<	O
0.001	O
)	O
and	O
postoperative	O
transfusions	B:C0005841
(	O
45.6	O
%	O
versus	O
40.1	O
;	O
p	O
<	O
0.001	O
)	O
in	O
the	O
intervention	O
group	I:C2986530
,	O
while	O
maintaining	O
a	O
higher	O
hematocrit	I:C0518014
at	O
discharge	O
(	O
28.1	O
versus	O
29.1	O
;	O
p	O
<	O
0.001	O
)	O
.	O

The	O
combination	O
was	O
associated	O
with	O
reduced	O
intraoperative	O
(	O
44.6	O
%	O
versus	O
34.1	O
;	O
p	O
<	O
0.001	O
)	O
and	O
postoperative	O
transfusions	O
(	O
45.6	O
%	O
versus	O
40.1	O
;	O
p	O
<	O
0.001	O
)	O
in	O
the	O
intervention	B:C2986530
group	I:C2986530
,	O
while	O
maintaining	O
a	O
higher	O
hematocrit	I:C0518014
at	O
discharge	O
(	O
28.1	O
versus	O
29.1	O
;	O
p	O
<	O
0.001	O
)	O
.	O

The	O
combination	O
was	O
associated	O
with	O
reduced	O
intraoperative	O
(	O
44.6	O
%	O
versus	O
34.1	O
;	O
p	O
<	O
0.001	O
)	O
and	O
postoperative	O
transfusions	O
(	O
45.6	O
%	O
versus	O
40.1	O
;	O
p	O
<	O
0.001	O
)	O
in	O
the	O
intervention	O
group	I:C2986530
,	O
while	O
maintaining	O
a	O
higher	B:C0518014
hematocrit	I:C0518014
at	O
discharge	O
(	O
28.1	O
versus	O
29.1	O
;	O
p	O
<	O
0.001	O
)	O
.	O

The	O
combination	O
was	O
associated	O
with	O
reduced	O
intraoperative	O
(	O
44.6	O
%	O
versus	O
34.1	O
;	O
p	O
<	O
0.001	O
)	O
and	O
postoperative	O
transfusions	O
(	O
45.6	O
%	O
versus	O
40.1	O
;	O
p	O
<	O
0.001	O
)	O
in	O
the	O
intervention	O
group	I:C2986530
,	O
while	O
maintaining	O
a	O
higher	O
hematocrit	I:C0518014
at	O
discharge	B:C0012621
(	O
28.1	O
versus	O
29.1	O
;	O
p	O
<	O
0.001	O
)	O
.	O

Finally	O
,	O
the	O
intervention	B:C0184661
was	O
associated	O
with	O
a	O
statistically	O
significant	O
reduction	O
in	O
the	O
O/E	O
for	O
reoperation	O
(	O
p	O
=	O
0.003	O
)	O
.	O

Finally	O
,	O
the	O
intervention	O
was	O
associated	O
with	O
a	O
statistically	O
significant	O
reduction	O
in	O
the	O
O/E	O
for	O
reoperation	B:C0035110
(	O
p	O
=	O
0.003	O
)	O
.	O

Use	O
of	O
streamlined	O
cardiopulmonary	O
bypass	O
circuit	O
and	O
rotational	B:C3661505
thromboelastometry	I:C3661505
may	O
reduce	O
transfusion	O
and	O
reoperation	O
rates	O
and	O
improve	O
perioperative	O
anemia	O
in	O
cardiac	O
surgical	I:C0018821
patients	O
.	O

Use	O
of	O
streamlined	O
cardiopulmonary	O
bypass	O
circuit	O
and	O
rotational	O
thromboelastometry	I:C3661505
may	O
reduce	O
transfusion	B:C0005841
and	O
reoperation	O
rates	O
and	O
improve	O
perioperative	O
anemia	O
in	O
cardiac	O
surgical	I:C0018821
patients	O
.	O

Use	O
of	O
streamlined	O
cardiopulmonary	O
bypass	O
circuit	O
and	O
rotational	O
thromboelastometry	I:C3661505
may	O
reduce	O
transfusion	O
and	O
reoperation	B:C0035110
rates	O
and	O
improve	O
perioperative	O
anemia	O
in	O
cardiac	O
surgical	I:C0018821
patients	O
.	O

Use	O
of	O
streamlined	O
cardiopulmonary	O
bypass	O
circuit	O
and	O
rotational	O
thromboelastometry	I:C3661505
may	O
reduce	O
transfusion	O
and	O
reoperation	O
rates	O
and	O
improve	O
perioperative	O
anemia	B:C0002871
in	O
cardiac	O
surgical	I:C0018821
patients	O
.	O

Use	O
of	O
streamlined	O
cardiopulmonary	O
bypass	O
circuit	O
and	O
rotational	O
thromboelastometry	I:C3661505
may	O
reduce	O
transfusion	O
and	O
reoperation	O
rates	O
and	O
improve	O
perioperative	O
anemia	O
in	O
cardiac	B:C0018821
surgical	I:C0018821
patients	O
.	O

This	O
study	O
demonstrates	O
reproducible	O
intraoperative	O
methods	O
for	O
reducing	B:C0005841
blood	I:C0005841
product	I:C0005841
usage	I:C0005841
and	O
improving	O
outcomes	O
.	O

